CoverageForm 410-K10-Q8-K13D13G13F

MRSH · Marsh & McLennan Companies, Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · MRSH

Income Statement

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue$26.98B$24.46B($62.00M)$2.02B--
Cost of Revenue------
Gross Profit------
R&D------
SG&A------
Total Operating Expenses$20.76B$18.64B$17.45B$16.44B$15.51B$14.16B
D&A$361.00M$369.00M$713.00M$719.00M$747.00M$741.00M
Operating Income$6.22B$5.82B$5.28B$4.28B$4.31B$3.07B
Interest Expense$960.00M$700.00M$578.00M$469.00M$444.00M$515.00M
Income Tax$1.30B$1.36B$1.22B$995.00M$1.03B$747.00M
Net Income$4.16B$4.06B$3.76B$3.05B$3.14B$2.02B
EPS - Basic$8.48$8.26$7.60$6.11$6.20$3.98
EPS - Diluted$8.43$8.18$7.53$6.04$6.13$3.94

Balance Sheet

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash & Equivalents$2.69B$2.40B$3.36B$1.44B$1.75B$2.09B
Accounts Receivable$7.67B$7.16B$6.42B$5.85B$5.59B$5.33B
Inventory------
Accounts Payable------
Current Assets$23.20B$22.12B$21.75B$8.30B$8.26B$8.15B
Total Assets$58.71B$56.48B$48.03B$33.45B$34.39B$33.05B
Current Liabilities$21.06B$19.52B$19.80B$7.17B$6.65B$6.56B
Long-term Debt$18.32B$19.43B$11.84B$11.23B$10.93B$10.80B
Total Liabilities------
Stockholders' Equity$15.31B$13.54B$12.37B$10.75B$11.22B$9.26B
Retained Earnings$27.77B$25.31B$22.76B$20.30B$18.39B$16.27B

Cash Flow

Line itemFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Operating Cash Flow$5.29B$4.30B$4.26B$3.46B$3.52B$3.38B
Investing Cash Flow($845.00M)($8.82B)($1.42B)($850.00M)($1.16B)($814.00M)
Financing Cash Flow($4.63B)$4.46B($1.12B)($1.05B)($1.30B)($1.88B)
CapEx$291.00M$316.00M$416.00M$470.00M$406.00M$348.00M
Free Cash Flow$5.00B$3.99B$3.84B$3.00B$3.11B$3.03B

Ratios

MetricFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Profitability
Gross margin------
Operating margin23.1%23.8%-8519.4%212.2%--
EBITDA margin24.4%25.3%-9669.4%247.8%--
Net margin15.4%16.6%-6058.1%151.2%--
Free cash flow margin18.5%16.3%-6196.8%148.5%--
FCF / Net income1.200.981.020.980.991.50
R&D / Revenue------
SG&A / Revenue------
Effective tax rate23.9%25.1%24.6%24.6%24.8%27.0%
Return on assets7.1%7.2%7.8%9.1%9.1%6.1%
Return on equity27.2%30.0%30.4%28.4%28.0%21.8%
Return on invested capital14.1%13.2%16.5%14.7%14.6%11.2%
Liquidity
Current ratio1.101.131.101.161.241.24
Quick ratio1.101.131.101.161.241.24
Cash ratio0.130.120.170.200.260.32
Leverage
Debt / Equity1.201.440.961.040.971.17
Debt / Assets0.310.340.250.340.320.33
Debt / EBITDA2.783.141.982.252.162.84
Interest coverage6.5x8.3x9.1x9.1x9.7x6.0x
Equity multiplier3.834.173.883.113.063.57
Liabilities / Assets------
Efficiency
Asset turnover0.460.43-0.000.06--
Inventory turnover------
Days sales outstanding104d107d-37783d1059d--
Days inventory outstanding------
Days payable outstanding------
Cash conversion cycle------
Valuation
P / E22.0x26.0x----
P / B6.0x7.8x----
P / S3.4x4.3x----
EV / EBITDA16.3x19.8x----
Growth
Revenue growth (YoY)10.3%-39548.4%-103.1%---
Revenue CAGR (3y)137.4%-----
Revenue CAGR (5y)------
Gross profit growth (YoY)------
Operating income growth (YoY)7.0%10.1%23.4%-0.7%40.6%14.5%
Net income growth (YoY)2.5%8.1%23.1%-3.0%55.9%15.7%
EPS growth (YoY)3.1%8.6%24.7%-1.5%55.6%15.5%
EPS CAGR (3y)11.8%10.1%24.1%21.0%23.8%11.1%
EPS CAGR (5y)16.4%19.1%18.4%16.0%12.6%5.7%
FCF growth (YoY)25.5%3.7%28.3%-3.7%2.5%56.4%
FCF CAGR (5y)10.5%15.5%12.7%13.5%12.1%14.2%
Book value growth (YoY)13.2%9.4%15.1%-4.2%21.2%16.6%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$23.45B total
Riskand Insurance Services Segment$17.27B · 73.6%
Consulting Segment$6.19B · 26.4%

Product / service

$6.19B total
Wealth$2.82B · 45.5%
Health$2.28B · 36.9%
Career$1.09B · 17.6%

Geographic

$27.06B total
US$13.34B · 49.3%
Other Geographic Areas$9.90B · 36.6%
GB$3.82B · 14.1%

Stability scores

Piotroski F-score

FY 2025 · 9-point quality

6/9
Neutral
  • Net income positive
  • Operating cash flow positive
  • ROA improved YoY
  • Cash flow > net income
  • Long-term debt decreased
  • Current ratio improved
  • No share dilution
  • -Gross margin improved
  • Asset turnover improved

Peer comparison

Same SIC group: Insurance Agents, Brokers & Service

CompanyRevenue (last FY)Net marginROE
WTW$9.71B16.5%20.1%
ERIE$4.07B13.8%24.5%
ACT$1.24B55.7%12.8%
AJG$13.94B10.7%6.4%
EQH$11.66B-11.8%1864.9%

Comparing MARSH & MCLENNAN COMPANIES against the 5 most active filers in the same SIC group.

Dividends

$3.60/share trailing 12 months · +10.4% YoY

Ex-datePer share
Apr 9, 2026$0.9000
Jan 29, 2026$0.9000
Oct 2, 2025$0.9000
Jul 24, 2025$0.9000
Apr 3, 2025$0.8150
Jan 30, 2025$0.8150
Oct 4, 2024$0.8150
Jul 25, 2024$0.8150
Apr 3, 2024$0.7100
Jan 24, 2024$0.7100
Oct 5, 2023$0.7100
Jul 26, 2023$0.7100
Apr 4, 2023$0.5900
Jan 25, 2023$0.5900
Oct 6, 2022$0.5900
Jul 27, 2022$0.5900
Apr 5, 2022$0.5350
Jan 26, 2022$0.5350
Oct 7, 2021$0.5350
Jul 28, 2021$0.5350
Apr 6, 2021$0.4650
Jan 29, 2021$0.4650
Oct 8, 2020$0.4650
Jul 24, 2020$0.4650

Cells marked with a small ◇ are sourced from SEC's bulk Financial Statement Data Sets, which can lose dimensional context (notably Revenue and Operating Income for issuers that report by segment). These cells will be replaced with authoritative values from the Company Facts API as the backfill completes.